11 Sep 2020

Disposals of own shares

Read More
9 Sep 2020

Final Phase II Results for UCB’s Rozanolixizumab in Primary Immune Thrombocytopenia (ITP) Published in Blood Advances

Read More
4 Sep 2020

Disposals of own shares

Read More
31 Aug 2020

Phase 3 data on VIMPAT[®] (lacosamide) in primary generalized tonic-clonic seizures published in Journal of Neurology, Neurosurgery & Psychiatry

Read More
28 Aug 2020

Disposals of own shares

Read More
21 Aug 2020

Disposals of own shares

Read More
10 Aug 2020

Acquisitions and disposals of own shares

Read More
5 Aug 2020

CIMZIA[®] is the First and Only Biologic Approved in Europe with the Option for a Reduced Maintenance Dose for Patients Across the Full Axial Spondyloarthritis Spectrum

Read More
30 Jul 2020

Acquisitions and disposals of own shares

Read More
30 Jul 2020

Transparency notification FMR LLC.

Read More
Subscribe to